#PancreaticCancer is often diagnosed late, when treatment options are limited.
Our SAFE-D trial is evaluating a blood test to try and spot the very earliest signs of the #cancer developing.
#PurpleForPancreaticCancer #MostProudOf
#PancreaticCancer is often diagnosed late, when treatment options are limited.
Our SAFE-D trial is evaluating a blood test to try and spot the very earliest signs of the #cancer developing.
#PurpleForPancreaticCancer #MostProudOf
A new trial, funded by @prostateuk.bsky.social, will look at whether selecting patients who may require more intensive treatment can improve outcomes for those with metastatic disease.
Find out more - bit.ly/3JRh0IO
A new trial, funded by @prostateuk.bsky.social, will look at whether selecting patients who may require more intensive treatment can improve outcomes for those with metastatic disease.
Find out more - bit.ly/3JRh0IO
Thank you to the 758 people who have taken part so far, and to all the #research teams involved.
The trial is seeing if a simple blood test can spot the earliest signs of 10 different #cancers.
Find out more 👇
Thank you to the 758 people who have taken part so far, and to all the #research teams involved.
The trial is seeing if a simple blood test can spot the earliest signs of 10 different #cancers.
Find out more 👇
Our #EarlyDiagnosis team is running the SAFE-D study, evaluating a new test to spot the early signs of #PancreaticCancer.
Find out more - safe-d.uk
Our #EarlyDiagnosis team is running the SAFE-D study, evaluating a new test to spot the early signs of #PancreaticCancer.
Find out more - safe-d.uk
If you missed the report on our Sleep Buddy study on BBC South Today yesterday, you can catch it on iPlayer until 7pm today
📺Watch from 11:20
www.bbc.co.uk/iplayer/epis...
@nihr.bsky.social @uhsftresearch.bsky.social
If you missed the report on our Sleep Buddy study on BBC South Today yesterday, you can catch it on iPlayer until 7pm today
📺Watch from 11:20
www.bbc.co.uk/iplayer/epis...
@nihr.bsky.social @uhsftresearch.bsky.social
The study is testing a new digital resource for families of children with #ADHD and #SleepProblems.
Listen to lead researchers Prof Sam Cortese (07:11) and Prof Cathy Hill (08:09) 👇
www.bbc.co.uk/sounds/play/...
The study is testing a new digital resource for families of children with #ADHD and #SleepProblems.
Listen to lead researchers Prof Sam Cortese (07:11) and Prof Cathy Hill (08:09) 👇
www.bbc.co.uk/sounds/play/...
The Sleep Buddy website has been developed by experts alongside parents and carers of children suffering ADHD-related sleep issues.
It's now being trialled in a UK-wide study.
Read more - bit.ly/3JKvkTc
@nihr.bsky.social
The Sleep Buddy website has been developed by experts alongside parents and carers of children suffering ADHD-related sleep issues.
It's now being trialled in a UK-wide study.
Read more - bit.ly/3JKvkTc
@nihr.bsky.social
Are you a parent or carer of a child aged 6-12 yrs, with a diagnosis of ADHD? We’re running a study to see if a new website can help.
Find out more & register - www.trial-deck.com/trial/sleepb...
#ADHDAwarenessMonth #SleepProblems
Are you a parent or carer of a child aged 6-12 yrs, with a diagnosis of ADHD? We’re running a study to see if a new website can help.
Find out more & register - www.trial-deck.com/trial/sleepb...
#ADHDAwarenessMonth #SleepProblems
The UNIVERSAL study is finding new ways to prevent and treat these infections, and recently recruited its 900th participant!
Find out more - bit.ly/3JkvXmt
The UNIVERSAL study is finding new ways to prevent and treat these infections, and recently recruited its 900th participant!
Find out more - bit.ly/3JkvXmt
Great to see so many youngsters (and adults!) playing our games and inspired by research!
Great to see so many youngsters (and adults!) playing our games and inspired by research!
He was talking about the @su2c.bsky.social-funded OptiMATe trial and how it is giving hope to patients with a rare form of #BloodCancer.
Catch the full report on tonight's programme at 6.30pm.
He was talking about the @su2c.bsky.social-funded OptiMATe trial and how it is giving hope to patients with a rare form of #BloodCancer.
Catch the full report on tonight's programme at 6.30pm.
Caroline was diagnosed with a rare #BloodCancer in 2023 & was the first person to take part in the @su2c.bsky.social OptiMATe trial.
The trial is giving hope to patients with this aggressive disease.
bit.ly/3KXPedZ
Caroline was diagnosed with a rare #BloodCancer in 2023 & was the first person to take part in the @su2c.bsky.social OptiMATe trial.
The trial is giving hope to patients with this aggressive disease.
bit.ly/3KXPedZ
The 100th patient was recruited at @gstt-nhs.bsky.social .
VALUE aims to improve decision-making about the best treatment pathways for these patients.
Find out more - bit.ly/3xmHjQH
@nihr.bsky.social @cardiffuni.bsky.social
The 100th patient was recruited at @gstt-nhs.bsky.social .
VALUE aims to improve decision-making about the best treatment pathways for these patients.
Find out more - bit.ly/3xmHjQH
@nihr.bsky.social @cardiffuni.bsky.social
It's aiming to improve outcomes for patients with #OesophagealCancer who are at high risk of the #cancer returning.
Visit our participant website to find out more - bit.ly/3HrYYf6
It's aiming to improve outcomes for patients with #OesophagealCancer who are at high risk of the #cancer returning.
Visit our participant website to find out more - bit.ly/3HrYYf6
200 participants with type 2 #diabetes have now been recruited to take part.
The study is evaluating a blood test that aims to improve the #EarlyDetection of #PancreaticCancer.
Find out more - bit.ly/44bgkoS
200 participants with type 2 #diabetes have now been recruited to take part.
The study is evaluating a blood test that aims to improve the #EarlyDetection of #PancreaticCancer.
Find out more - bit.ly/44bgkoS
These temporary devices have their advantages but are not always successful.
@unisouthampton.bsky.social’s Ali Mosayyebi has developed a new type of stent that is being trialled at @uhsft.bsky.social and UCLH 🏥
Learn more in just 3️⃣0️⃣ seconds 📽
It uses novel engineering techniques to reduce blockages and infections.
www.dailyecho.co.uk/news/2553503...
It uses novel engineering techniques to reduce blockages and infections.
www.dailyecho.co.uk/news/2553503...
Their team raised over £3.5k for life-saving #research.
www.bbc.co.uk/news/article...
Their team raised over £3.5k for life-saving #research.
www.bbc.co.uk/news/article...
A first-in-human trial has started @uhsft.bsky.social & @uclh.bsky.social of a new urinary stent designed with novel #engineering techniques.
The aim is to reduce infections & improve the lives of patients.
Read more - bit.ly/4mX1Eju
@nihr.bsky.social
A first-in-human trial has started @uhsft.bsky.social & @uclh.bsky.social of a new urinary stent designed with novel #engineering techniques.
The aim is to reduce infections & improve the lives of patients.
Read more - bit.ly/4mX1Eju
@nihr.bsky.social
This #ClinicalTrial is seeing if a simple blood test can detect #melanoma returning earlier than a routine scan.
A larger phase III trial is now being planned.
Read more - bit.ly/3YRtqok
@cancerresearchuk.org
This #ClinicalTrial is seeing if a simple blood test can detect #melanoma returning earlier than a routine scan.
A larger phase III trial is now being planned.
Read more - bit.ly/3YRtqok
@cancerresearchuk.org
Our study aims to test whether a new website, Sleep Buddy, improves sleep problems in children aged 6-12 years with ADHD.
Find out more and register your interest - www.trial-deck.com/trial/sleepb...
Our study aims to test whether a new website, Sleep Buddy, improves sleep problems in children aged 6-12 years with ADHD.
Find out more and register your interest - www.trial-deck.com/trial/sleepb...
A new tool, developed by the @ukcrc-ctu.org.uk network, including the team at SCTU, helps trial teams navigate the process.
Full article below 👇
Trial teams can now better manage #ProtocolDeviations using the #UKCTUNetwork developed Routemap which has been designed to support safer, more compliant research.
Find out more here: ukcrc-ctu.org.uk/deviations-r...
#WorldPatientSafetyDay2025 #ClinicalResearch
A new tool, developed by the @ukcrc-ctu.org.uk network, including the team at SCTU, helps trial teams navigate the process.
Full article below 👇
Join a new #ClinicalTrial to help improve the #EarlyDiagnosis of #PancreaticCancer.
We're evaluating a new blood test to spot the signs of #cancer in its earliest stage.
Find out more and register – www.safe-d.uk
Join a new #ClinicalTrial to help improve the #EarlyDiagnosis of #PancreaticCancer.
We're evaluating a new blood test to spot the signs of #cancer in its earliest stage.
Find out more and register – www.safe-d.uk
#Research is helping to:
- Find better & faster ways to diagnose #cancer
- Find more effective & kinder treatments
- Personalise treatment to individual patients
Find out more about our #ClinicalTrials - bit.ly/40QAqn4
@ukcrc-ctu.org.uk @cancerresearchuk.org
#Research is helping to:
- Find better & faster ways to diagnose #cancer
- Find more effective & kinder treatments
- Personalise treatment to individual patients
Find out more about our #ClinicalTrials - bit.ly/40QAqn4
@ukcrc-ctu.org.uk @cancerresearchuk.org
Results from the RiVa trial suggest giving two different treatments, one to activate immune cells and one to flag cancer cells, could have benefits for some patients.
Full paper👉https://bit.ly/4pzf7jW
Results from the RiVa trial suggest giving two different treatments, one to activate immune cells and one to flag cancer cells, could have benefits for some patients.
Full paper👉https://bit.ly/4pzf7jW